| Bioactivity | AIC-292 is a potent and selective inhibitor of HIV-1 nonnucleoside reverse transcriptase. AIC-292 inhibits wild-type HIV-1 laboratory strains at low nanomolar concentrations. AIC-292 displays potent antiviral in vivo efficacy in a mouse xenograft model. AIC-292 has the potential for the research of HIV-1 infection[1]. |
| Name | AIC-292 |
| CAS | 1187917-12-9 |
| Formula | C19H12Cl2F2N4O2 |
| Molar Mass | 437.23 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wildum S, et al. In vitro and in vivo activities of AIC292, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor. Antimicrob Agents Chemother. 2013;57(11):5320-5329. |
AIC-292
CAS: 1187917-12-9 F: C19H12Cl2F2N4O2 W: 437.23
AIC-292 is a potent and selective inhibitor of HIV-1 nonnucleoside reverse transcriptase. AIC-292 inhibits wild-type HIV
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.